Financial reports
10-K
2023 FY
Annual report
28 Feb 24
10-Q
2023 Q3
Quarterly report
1 Nov 23
10-Q
2023 Q2
Quarterly report
2 Aug 23
10-Q
2023 Q1
Quarterly report
3 May 23
ARS
2022 FY
Annual report to shareholders
26 Apr 23
10-K/A
2022 FY
Annual report (amended)
14 Apr 23
10-K
2022 FY
Annual report
1 Mar 23
10-Q
2022 Q3
Quarterly report
2 Nov 22
10-Q
2022 Q2
Quarterly report
3 Aug 22
10-Q
2022 Q1
Quarterly report
4 May 22
Current reports
8-K
Departure of Directors or Certain Officers
22 Mar 24
8-K
Results of Operations and Financial Condition
28 Feb 24
8-K
Other Events
12 Feb 24
8-K
Results of Operations and Financial Condition
8 Jan 24
8-K
Results of Operations and Financial Condition
1 Nov 23
8-K
Departure of Directors or Certain Officers
21 Sep 23
8-K
Results of Operations and Financial Condition
2 Aug 23
8-K
Submission of Matters to a Vote of Security Holders
16 Jun 23
8-K
Entry into a Material Definitive Agreement
9 Jun 23
8-K
G1 Therapeutics Provides First Quarter 2023 Financial Results and Operational Highlights
3 May 23
Registration and prospectus
S-8
Registration of securities for employees
1 Nov 23
424B5
Prospectus supplement for primary offering
18 Nov 22
424B5
Prospectus supplement for primary offering
17 Nov 22
S-8
Registration of securities for employees
24 Jun 22
POS AM
Prospectus update (post-effective amendment)
23 Feb 22
POSASR
Automatic shelf registration (post-effective amendment)
23 Feb 22
S-3ASR
Automatic shelf registration
2 Jul 21
S-8
Registration of securities for employees
25 Mar 21
S-8
Registration of securities for employees
3 Feb 20
S-8
Registration of securities for employees
14 Jun 19
Proxies
PRE 14A
Preliminary proxy
12 Apr 24
DEFA14A
Additional proxy soliciting materials
26 Apr 23
DEF 14A
Definitive proxy
26 Apr 23
DEFA14A
Additional proxy soliciting materials
28 Apr 22
DEF 14A
Definitive proxy
28 Apr 22
DEFA14A
Additional proxy soliciting materials
28 Apr 21
DEF 14A
Definitive proxy
28 Apr 21
DEFA14A
Additional proxy soliciting materials
24 Apr 20
DEF 14A
Definitive proxy
24 Apr 20
DEFA14A
Additional proxy soliciting materials
30 Apr 19
Other
UPLOAD
Letter from SEC
8 Jun 23
CORRESP
Correspondence with SEC
14 Apr 23
UPLOAD
Letter from SEC
7 Apr 23
EFFECT
Notice of effectiveness
4 May 22
EFFECT
Notice of effectiveness
7 Mar 18
CORRESP
Correspondence with SEC
5 Mar 18
CORRESP
Correspondence with SEC
5 Mar 18
UPLOAD
Letter from SEC
1 Mar 18
CT ORDER
Confidential treatment order
17 May 17
EFFECT
Notice of effectiveness
16 May 17
Ownership
144
Notice of proposed sale of securities
9 Apr 24
4
Monica R. Thomas
22 Mar 24
4
Mark Avagliano
22 Mar 24
4
John W. V Umstead
22 Mar 24
4
John W. V Umstead
20 Mar 24
SC 13D/A
ESHELMAN FREDRIC N
21 Feb 24
4
Rajesh Malik
13 Feb 24
144
Notice of proposed sale of securities
12 Feb 24
144
Notice of proposed sale of securities
9 Jan 24
4
John W. V Umstead
8 Jan 24